• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number GSX0025A
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Bacterial Infection (1735); Embolism (1829); Fever (1858)
Event Date 07/10/2019
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing and sterilization records verified the lot was processed normally and all pre-release specifications were met.Case images and images of the explanted device (device not returned) were received by gore for analysis.The imaging and engineering evaluations are in progress.
 
Event Description
It was reported the physician implanted a 25mm gore® cardioform septal occluder to close an atrial septal defect on (b)(6) 2019.The patient presented recently with an acute onset fever, malaise and back pain.Multiple blood cultures were positive with s aureus.A brain mri demonstrated multi focal septic emboli in the cerebrum and cerebellum.The patient's neurological exam was normal.On (b)(6) 2019, transesophageal echocardiology showed a vegetation on the left atrial surface of the occluder.On (b)(6) 2019, the device was explanted the defect was surgically closed.The patient did well following the surgery and was discharged after seven days with no long term neurologic concerns.
 
Manufacturer Narrative
Electronic files containing digital echocardiography images were received for review.The imaging shows a gore® caridoform septal occluder deployed on the atrial septum.The left and right discs appear to be on their appropriate side of the atrial septum and in good position.An echogenic mass that is consistent with a vegetation is seen on the surface of the left atrial disc of the device.Images of the explanted device were provided for review; however, an engineering analysis cannot be completed due to the state of the device in the returned images.The cause of the symptoms experienced by the patient and reported vegetation on the left atrial disc surface is unknown and cannot be determined from the returned images.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8888078
MDR Text Key154136469
Report Number2017233-2019-00624
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00733132631025
UDI-Public00733132631025
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 08/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/11/2020
Device Catalogue NumberGSX0025A
Device Lot Number18347655
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/13/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age6 YR
-
-